The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
August 18th 2025
In a new review of MRI-based scoring systems for T-staging of prostate cancer, researchers discuss key literature findings and principles in evaluating the extent of prostate cancer (PCa) lesions, and whether a focus on specificity could enhance the staging of PCa.
MR colonography evolves to meet screening needs
March 3rd 2006MR colonography has yet to capture radiologists’ imagination to the same extent as CT. But the radiation-free exam has a bright future, especially if stool tagging techniques can avoid the need for bowel cleansing, according to speakers from the U.S. and Greece at ECR on Friday.
Radiologists add value to multidisciplinary cancer team
March 2nd 2006As cancer is discovered earlier and therapy administered sooner, patients are living longer. The role of imaging in cancer is increasing, bringing radiologists closer to the heart of the multidisciplinary care team. A categorical course at the ECR explored this topic.
Imaging of shoulder opens new turf fight for radiologists
March 1st 2006Although musculoskeletal radiologists have long debated the relative roles of MRI and ultrasound in imaging shoulder injuries, they have reached consensus on a number of diagnostic algorithms. But the proliferation of inexpensive, low-end compact ultrasound systems has introduced a new controversy.
MSK radiologist questions shoulder ultrasound data
March 1st 2006After reviewing the clinical literature on ultrasound imaging of the shoulder, Dr. David Stoller, director of musculoskeletal MRI at the California Pacific Medical Center in San Francisco, concluded that a significant amount of data was either flawed or inaccurate.
Nuclear medicine society serves up online CME
March 1st 2006The Society of Nuclear Medicine's recently launched Lifelong Learning and Self-Assessment Program offers online modules to help physicians comply with new maintenance of certification requirements, including 20 nuclear medicine-specific CME credits every year.
'Mr. January' wears a Nobel medal
February 11th 2006This is one pinup calendar you probably won't find in your mechanic's garage. The "Big Brains on Campus" calendar features artistically enhanced MR brain scans of University of Illinois administrators, faculty, staff, and students. It serves as a promotion for the Beckman Institute for Advanced Science and Technology.
MR imaging evaluates ulcerative colitis cases
February 11th 2006Advances in MR technology have improved the quality of abdominal MRI and hence the ability to assess intestinal diseases. Rapid acquisition sequences have reduced the incidence of motion artifacts from intestinal peristalsis, while the use of phased-array coils has increased spatial resolution. Several intestinal contrast agents have undergone extensive trials. Meanwhile, the use of sequences that modulate MRI signal selectively, for example by suppressing fat tissue signal, can improve gadolinium-related enhancement on T1-weighted images, as well as boosting T2 signal in pathologic tissues.
MRA contrast selection expands with new compounds
February 11th 2006Contrast agents that can aid MRA examinations have been on the market for more than 15 years. Historically, radiologists could choose from a wide range of agents that, once injected intravenously, would flow through the extracellular space. They would then be excreted from the body relatively rapidly. These extracellular contrast agents are now being joined by a new class of blood pool, or intravascular, contrast agents that bind with molecules in the blood and stay in the circulation for longer.
Coronary MRA struggles against success of CTA
February 11th 2006The failure of MRA to make major inroads into coronary angiography is not due to lack of trying. Many different techniques have been attempted, often with encouraging results. Additional clinical trials, involving both healthy volunteers and patients, are ongoing. But promising research results in a controlled environment are no guarantee of clinical viability.
MRA evolves to meet changing clinical needs
February 11th 2006Contrast-enhanced MR angiography is the primary method of assessing vascular disease at many hospitals worldwide. While advances in technology ensure that CT angiography draws its share of devotees, MRA continues to win hearts and minds among radiologists who prefer the radiation-free imaging approach.
Vendors refine offerings to boost efficiency
February 11th 2006In the wake of the U.S. holiday of Thanksgiving every year, a city rises within the confines of Chicago's McCormick Place. It is a kind of radiological Epcot Center, a futuristic vision designed to dazzle; constructed of software, heavy iron, and handhelds; and swathed in platitudes.
Imaging offers insight into blood-brain permeability
February 11th 2006Neuroradiologists understand that high-grade tumors interrupt the blood-brain barrier, which presents as contrast enhancement on CT and MRI. Renewed interest in the phenomenon of permeability, however, has researchers looking beyond simple contrast enhancement and toward molecular mechanisms involved in permeability that may help them treat brain tumors more effectively.
Convert turf battles into productive joint ventures
February 11th 2006Since the introduction of cardiac catheterization in the 1940s, development and implementation of cardiovascular imaging techniques have been a collaborative effort among several specialties, particularly radiology and cardiology. Many pioneers in CV imaging have held joint appointments.
Poster prizewinners include controversial imaging agent
February 11th 2006On the same day that New York researchers received the top honor at the RSNA meeting for their poster detailing the benefits of an infection imaging agent, the drug's maker issued a warning about two deaths and additional serious adverse events attributed to the drug's use. The admonition was released by Tyco Mallinckrodt Healthcare, which markets NeutroSpec (technetium-99m fanolesomab), a monoclonal antibody-labeled radiopharmaceutical agent approved in the U.S. for the diagnosis of equivocal appendicitis.
Report from SCMR: MR travels a long way to test blood disease treatment
February 6th 2006In a laborious clinical trial that involved hauling a mobile MR scanner over land and sea to the Mediterranean island of Sardinia, British researchers used T2* imaging to confirm the value of a new drug treatment for Β-thalassemia, a genetic blood disorder.
Brain MRI stands up to polygraph test
January 30th 2006Traditional polygraph tests to determine whether someone is lying may take a back seat to fMRI, according to a study in the February issue of Radiology. Researchers from Temple University Hospital used fMRI to show how specific areas of the brain light up when a person tells a lie.